Distamin

Quick links to important sections

Distamin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Distamin

What is Distamin?

Distamin is a pharmacological agent primarily categorized as a chelating agent. Its active medicinal component is penicillamine, a crystalline compound derived from the degradation of penicillin antibiotics, though it does not possess antibiotic properties itself.

Mechanism of Action

The primary function of Distamin involves its ability to bind with certain heavy metals in the body to form stable, soluble complexes known as chelates. Once these metals are chemically bound to the drug, they are more easily filtered by the kidneys and excreted from the system through urine. This process is utilized to reduce toxic levels of metals such as copper, lead, mercury, and zinc.

In addition to its chelating properties, Distamin is recognized as a disease-modifying antirheumatic drug (DMARD). While its exact mechanism in treating inflammatory conditions is not fully understood, it is believed to suppress immune system activity and reduce the inflammatory response by interfering with the formation of collagen cross-links and affecting lymphocyte function.

Clinical Applications

Distamin is used in the management of several distinct medical conditions:

  • Wilson's Disease: A genetic disorder that causes excessive copper accumulation in the liver, brain, and other vital organs. Distamin facilitates the removal of this excess copper.
  • Cystinuria: A hereditary condition characterized by the formation of cystine stones in the kidneys, bladder, and ureters. Distamin reacts with cystine to form a more soluble compound, reducing the risk of stone crystallization.
  • Rheumatoid Arthritis: Used in cases of severe, active disease that has not responded to conventional treatments. It works to reduce joint swelling, pain, and stiffness over time.
  • Heavy Metal Poisoning: Utilized specifically for the removal of lead or other heavy metals from the body following acute or chronic exposure.

What side effects are possible with Distamin?

Possible Side Effects and Safety Information

The official safety profile of Distamin (Chlorphenamine maleate) is defined primarily by its classification as a first-generation sedating antihistamine. Adverse reactions are systematically grouped by their frequency and the system-organ class affected, according to government regulatory documentation.

Frequency-Classified Adverse Reactions

Classification Examples of Officially Documented Effects
Very Common Sedation, Somnolence (Drowsiness), Mental Clouding.
Common Dizziness, Headache, Dry mouth, Fatigue, Blurred vision, Disturbance in attention, Abnormal coordination.
Not Known Haemolytic anaemia, Anaphylaxis, Excitation, Confusion, Urinary retention, Photosensitivity.

These classifications establish that central nervous system (CNS) effects are the most frequently expected characteristic of the medicine.

Serious Safety Considerations

Regulatory labels document the potential for serious adverse reactions, including severe systemic reactions like anaphylaxis and angioedema, as well as potential blood dyscrasias such as haemolytic anaemia. While the frequency of these reactions is classified as 'Not Known,' they are recognized as important safety components.

Population-Specific Constraints

The safety profile includes explicit warnings for specific populations. Children and older adults are noted to be more susceptible to neurological effects, including paradoxical excitation (restlessness) and an increased risk of anticholinergic toxicity (e.g., confusion, urinary retention) due to potentially reduced drug clearance. The medication is also associated with safety constraints related to pre-existing conditions; caution is advised in cases of epilepsy, glaucoma, prostatic hypertrophy, and significant hepatic or renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving Chlorphenamine Maleate is formally documented in regulatory sources to present with a wide spectrum of effects on the central nervous system. Documented manifestations include both signs of CNS depression, such as marked sedation, confusion, and somnolence, and the potential for a paradoxical CNS stimulation, characterized by excitement, restlessness, and toxic psychosis. Additionally, severe anticholinergic effects like mydriasis and urinary retention are commonly documented signs.

The regulatory profile explicitly lists the risks of severe or life-threatening outcomes, including cardiovascular collapse, arrhythmias, hypotension, and apnoea (breathing cessation), which can lead to convulsions or coma. Due to the seriousness of these documented effects, the official guidance mandates that individuals must seek immediate medical attention or contact a Poison Control Center right away upon any suspected overdose.

No specific antidote is available for Chlorphenamine Maleate overdose, as affirmed by prescribing information. Therefore, management is defined as symptomatic and supportive measures, including close monitoring of cardiac and respiratory function. The regulatory documents note that children and the elderly are particularly susceptible to severe neurological effects and paradoxical excitation.

Therapeutic Uses of Distamin

What Distamin Treats: Main Uses and Benefits

The medication is commonly used to provide symptomatic relief in contexts involving heightened allergic responses. It is generally applied in situations involving certain distressing symptoms associated with allergic conditions, hay fever, and the common cold.

Distamin is relevant in conditions characterized by periods of heightened symptoms, helping manage the symptom clusters of allergic rhinitis, hives (urticaria), and allergic irritation from insect bites. The medication is commonly used to help with persistent symptoms like repetitive sneezing, excessive runny nose (rhinorrhea), and intense pruritus (itching). It contributes to easing the overall symptom load and supports the patient during difficult episodes. The medication is also applied in acute clinical settings where symptoms are temporarily overwhelming, offering supportive relief alongside primary treatments.

Quick Fact Symptom Management Focus
Primary Focus Allergic Rhinitis (Hay Fever)
Skin Relief Cutaneous Allergic Symptoms
Scenario Common Cold Symptom Management

Regulatory References

  1. NIH MedlinePlus overview of Chlorpheniramine

Eligibility and Restrictions for Use

Who Can and Cannot Use Distamin? (Official Regulatory Information)

Official regulatory documents define strict criteria regarding population eligibility for Distamin (Chlorphenamine maleate), primarily through absolute prohibitions (contraindications) and conditional use warnings.

Absolute Prohibitions (Contraindicated Populations)

  • Hypersensitivity: Patients with a known allergy to chlorphenamine maleate or any inactive ingredient must not use the medicine.
  • Drug Interactions: Use is contraindicated if the patient is currently receiving Monoamine Oxidase Inhibitor (MAOI) therapy or has stopped such therapy within the last 14 days.
  • Pediatric Age: The medicine is generally prohibited for use in children younger than 6 years of age in most common oral formulations.
  • Comorbidities: Contraindicated in patients with narrow-angle glaucoma or conditions leading to urinary retention.

Restricted and Conditional Use

Population/Condition Regulatory Status Constraint
Older Adults (65+) Use with Caution Increased susceptibility to adverse effects; lower maximum daily dose may be required.
Organ Impairment Use with Caution Patients with severe hepatic or severe renal impairment should consult a health professional.
Reproductive Status Ask a Doctor Consultation is required for women who are pregnant or breastfeeding.

These constraints ensure the medicine is only used by populations with an established safety profile according to governmental labeling.

What should I know about interactions with other medicines?

The officially documented interaction profile for Distamin (Chlorphenamine maleate) is governed by two principal types of interaction: pharmacodynamic potentiation and specific pharmacokinetic inhibition.

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated by regulatory authorities due to the intensification and prolongation of anticholinergic effects. A mandatory 14-day separation period is required after discontinuing MAOI therapy before initiating treatment with Distamin.

A prominent interaction domain involves additive Central Nervous System (CNS) depressant effects. Concurrent use with alcohol or other CNS depressants—such as hypnotics, opioid analgesics, and sedatives—potentiates the sedative effect. Similarly, co-administration with other anticholinergic drugs (e.g., Atropine or certain antidepressants) heightens the risk of antimuscarinic effects. Regulatory documents note that Chlorphenamine inhibits the metabolism of Phenytoin, leading to an increase in Phenytoin plasma concentrations and a risk of toxicity. Distamin should also not be used concurrently with any other product containing antihistamines. Caution is noted for patients with hepatic impairment, as they may be more susceptible to the severity of these documented interactions due to altered drug clearance.

Mechanism of Action

How Distamin Works: The Mechanism of Action

Peripheral Histamine H1 Receptor Inverse Agonism

Distamin (Chlorphenamine) works primarily by targeting the Histamine H1 receptor, acting as an inverse agonist to stabilize the receptor in an inactive state and competitively block the binding of endogenous histamine. This molecular action directly modifies the early steps of the histaminergic cascade, contributing to inhibiting histamine-driven increases in capillary permeability and the excitation of sensory nerves in peripheral tissues.

Central Nervous System H1 Receptor Antagonism

The molecule's lipophilic structure allows it to penetrate the blood-brain barrier effectively, where it engages H1 receptors within the Central Nervous System (CNS) arousal system. By antagonizing central histaminergic receptors, the mechanism reduces the excitatory input to cortical regions. This central receptor antagonism results in a reduction of vigilance and alertness.

Off-Target Muscarinic Acetylcholine Receptor Antagonism

A secondary aspect of Distamin's action is its competitive antagonism at muscarinic acetylcholine receptors (M(1), M(2), M(3)) located on various glands. This off-target binding interferes with cholinergic signaling responsible for glandular function, reducing functional output.

Dosage and Administration Information

How Distamin is Used: Official Administration Guidelines

The usage of Distamin (Chlorphenamine maleate) is defined by specific protocols, establishing precise routes, dosing, and scheduling rules.

Dosing and Administration

Feature Statement
Route of Administration Primarily Oral (tablets, solution/syrup). Parenteral (IV, IM, SC) for injection formulations, reserved for acute, medically supervised use.
Standard Adult Dose 4 mg immediate-release taken every 4 to 6 hours. Maximum total daily dose is 24 mg (not more than 6 doses in 24 hours).
Administration Timing Oral formulations may generally be taken with or without food.
Duration of Use For self-treatment, use should not be continued for more than two weeks without consulting a health professional.

Population-Specific Use Rules

  • Children 12 Years and Older: Follow the standard adult dosing regimen.
  • Children 6 to 12 Years: The standard dose is 2 mg (typically 1/2 of a 4 mg tablet or 5 mL of a 2 mg/5 mL syrup) every 4 to 6 hours, not to exceed a maximum of 12 mg per 24 hours.
  • Children Under 6 Years: Use is generally not recommended unless directed by a doctor.
  • Older Adults: Due to greater susceptibility to certain effects, consideration should be given to using a lower daily dose, such as a maximum of 12 mg in 24 hours.

Procedural Instructions

When administering the oral solution, an accurate milliliter (mL) measuring device must be used, as household spoons are not reliable for precise dosing. For parenteral administration, especially when given intravenously, the injection must be given slowly over a period of one minute to adhere to specified procedural constraints. Individuals with renal or hepatic impairment are advised to seek professional advice prior to taking the medicine.

Recent Clinical Evidence

1. Evidence for Use in Allergic Rhinitis (Hay Fever)

Research has primarily focused on evaluating the agent in the context of allergic rhinitis (hay fever). Studies explored short-term symptom changes using Randomized Controlled Trials (RCTs), where the agent was observed in populations of adults and older children. These studies monitored outcomes such as Total Symptom Scores (TSS) and assessments of individual symptoms like sneezing and runny nose (rhinorrhea). Findings describe patterns observed during the study periods, suggesting how symptoms evolved. Follow-up durations were limited, typically ranging from a few weeks up to 30 days. This contributes to the reason long-term outcomes are not fully established; the research base is largely historical.


2. Evidence for Use in Urticaria (Hives)

Research explored the agent in settings for urticaria (hives), focusing on the intensity of pruritus (itching) and the size and number of weals. Studies monitored how symptoms evolved in patients diagnosed with chronic idiopathic urticaria. The research base includes comparative trials and some studies that investigated the agent as part of a combination regimen. Data for certain groups remain insufficient, particularly when comparing the drug as a single agent against current standard-of-care treatments in large-scale contemporary RCTs.


3. Evidence for Use in Managing Common Cold Symptoms

Trials explored the agent for its relevance to short-term symptom patterns associated with the common cold. Research frequently examined the agent as an element of a fixed-dose combination product. Studies monitored outcomes describing episodic changes, and systematic reviews indicate that the measured effect on individual cold symptoms is often described as small. The primary research is often centered on the combination products, meaning the unique contribution of the agent as a single entity is not fully established.


4. What is Still Uncertain About Distamin Research

A primary limitation is that many trials were observed in earlier decades, meaning evidence quality varies across studies. It is not fully established whether specific, contemporary research is ongoing, and there is limited information for long-term outcomes for any of the main indications. Comparative evidence is lacking regarding the isolated effect of the agent in multi-drug cold products, and data for special groups, such as pregnant populations, remain insufficient.

Key Studies & References Chlorpheniramine: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Distamin (FAQ)


Q: Can Distamin be used long-term, or is it only for short-term use?

Official guidelines often limit the use of Distamin for self-treatment to a short duration, such as no more than two weeks. Long-term use is not typically covered in self-treatment guidelines; regulatory documents focus on short-term use, and prolonged administration requires consultation with a healthcare professional.


Q: Is it common for Distamin to cause vivid dreams or sleep changes?

Regulatory documents list a variety of adverse events affecting the nervous system. These include reports of confusion, irritability, and in some individuals, psychiatric effects such as nightmares or mental disturbances. Regulatory documents advise consulting a healthcare provider if any unusual or persistent adverse effects are experienced.


Q: Does Distamin interact with common pain relievers like ibuprofen or acetaminophen?

Regulatory warnings focus primarily on concurrent use with other sedating agents or products that contain antihistamines. Official regulatory information does not commonly list non-sedating pain relievers like ibuprofen or acetaminophen as known contraindications, but caution is advised with combination products.


Q: How long does it typically take for a person to notice the effects of Distamin?

Authoritative information suggests the onset of action is typically reported as occurring within 30 minutes to one hour after administration. This quick onset is related to the drug's rapid absorption into the body.


Q: What is the risk of dependence or withdrawal symptoms associated with Distamin?

The product information does not commonly feature physical dependence as a primary warning. However, clinical studies have examined the potential for a reduced response (subsensitivity) to the drug’s effects developing over time in some individuals.


Q: Can Distamin affect blood pressure, even in people without a heart condition?

Regulatory summaries list cardiovascular effects among the reported adverse events associated with Distamin. These changes can include hypotension (low blood pressure) and tachycardia (fast heart rate).


Q: Is there a generic version of Distamin available?

Yes, products containing the same active ingredient, Chlorphenamine maleate, are licensed and manufactured as generic alternatives. Regulatory agencies in various countries approve these alternatives.


Q: Is Distamin considered safe for use in older adults or senior populations?

Official information states that older adults may be more susceptible to certain effects, such as confusion and sedation. Due to increased sensitivity, regulatory documents note that a reduced maximum daily dose is sometimes considered for the senior population.


Q: Is it possible for a patient to develop tolerance to Distamin over time?

Evidence from clinical studies has shown that subsensitivity, or a reduced response to the medication's intended effects, may develop in some individuals. This has typically been noted after a few weeks of consistent use.


Q: What is the consensus in research about Distamin's effectiveness compared to no treatment?

Regulatory authorization is based on clinical research that supported the drug's use. The trials supported the drug's use in reducing the targeted symptoms, leading to its regulatory approval for specified indications.


Q: Are there any known interactions between Distamin and common herbal supplements, like St. John's Wort?

Official drug interaction summaries advise caution or avoidance when using complex herbal supplements like St. John's Wort alongside many prescription and over-the-counter medicines. This is due to the potential for St. John's Wort to affect how the body processes drugs.


Q: Can Distamin cause weight gain or weight loss?

Changes in appetite or body weight are not listed as a common effect in all regulatory documents. However, some official sources note that certain antihistamines, including this class, may be associated with changes in appetite or weight in some individuals.


Q: How should Distamin be stored to ensure it remains effective?

Official regulatory labels mandate specific storage conditions. Distamin should be kept in its original packaging at room temperature and protected from excess heat and moisture.


Q: Can Distamin be taken by people who have mild liver or kidney issues?

Regulatory guidelines caution that individuals with kidney (renal) or liver (hepatic) impairment should use this medication with care. The potential for altered drug clearance in these populations means that caution and possible dose modification are noted in regulatory information.


Q: Is the core research on Distamin primarily based on animal studies or human clinical trials?

The regulatory authorization of Distamin, like all approved medicines, is primarily based on evidence from human clinical trials. These human studies are supported by preclinical animal data used for initial safety and efficacy assessments.


Q: Why do some people experience nausea when they first start taking Distamin?

Nausea is a reported and listed adverse event found in regulatory documents, specifically under the gastrointestinal side effects section. It is described as a common effect associated with the use of this medicine.


Q: Is there a specific period during which side effects are most likely to appear?

Common acute side effects, such as drowsiness, typically occur soon after administration. These effects usually coincide with the time the medication begins to act or when drug levels reach their peak concentration in the body.


Q: Can Distamin affect the results of routine medical lab tests?

Regulatory documents specifically state that this medication may interfere with the results of certain skin tests used to diagnose allergies. Regulatory documents note that professional advice regarding temporary discontinuation may be necessary prior to certain skin tests.


Q: Are there any common medical conditions that make a person ineligible for Distamin?

Official documentation lists several conditions that may make a person ineligible to take Distamin. These contraindications include conditions such as narrow-angle glaucoma, peptic ulcer or obstruction, and symptoms related to prostate enlargement.


Q: What is the role of Distamin if a person's condition is mild?

The drug is indicated for the temporary relief of symptoms associated with allergic conditions. Regulatory documents define its role by the symptoms treated, not necessarily the subjective severity.


Q: Does taking Distamin require any specific monitoring, like regular blood tests?

Routine blood tests are not typically required for standard use of Distamin. However, regulatory warnings mention rare, serious adverse effects (e.g., blood cell changes), and these warnings may prompt specific monitoring if deemed necessary by a healthcare provider.


Q: How quickly does Distamin leave the body after the last dose?

The rate at which the medication is processed and cleared by the body is variable among individuals, but regulatory data on its elimination half-life is published in the product’s official documents.


Q: What kind of evidence is available about Distamin use in children or adolescents?

Regulatory documents specify distinct dosing and administration guidelines for children, typically beginning at age six. Strong warnings are present against the use of the medicine in children under two, or for cough and cold symptoms under four years of age.


Q: What are the most serious, but rare, side effects that regulatory bodies have described for Distamin?

Serious, but rare, adverse effects noted in official regulatory summaries include blood disorders such as agranulocytosis or hemolytic anemia. Other rare effects include convulsions (seizures) and severe allergic reactions.


Q: What is the difference between the brand name Distamin and its active ingredient?

The brand name Distamin is a commercial, proprietary name given to the product. The active ingredient, which is the chemical component responsible for the medicine's effects, is Chlorphenamine maleate.


Q: Do official documents mention any potential for long-term side effects after stopping Distamin?

Official documentation primarily focuses on effects during active use. However, some long-term reports have noted persistent side effects, such as movement disorders, that only partially resolved after discontinuing the medication.


Q: What precautions are described for pregnant or breastfeeding individuals regarding Distamin?

Official documents advise that the medication should generally be avoided during the third trimester of pregnancy. Regulatory documents state that use during breastfeeding requires careful consideration due to the potential for effects on the infant or the milk supply.


Q: Are there any specific mental or mood changes that Distamin is associated with?

Yes, regulatory documents list potential psychiatric effects. These changes can include confusion, excitement, irritability, and in rare cases, depression.


Q: Does the time of day matter when taking Distamin?

While the standard dosage schedule is regular intervals, due to the known sedative effects of the medication, the timing of doses, particularly considering nighttime use, is often mentioned in official patient guides to manage daytime alertness.


Q: Is Distamin available over-the-counter in any country?

The regulatory classification of the active ingredient varies by jurisdiction and formulation. In several countries, forms of this medicine are available for sale without a prescription.


Q: How is the safety profile of Distamin generally described in regulatory summaries?

Regulatory summaries describe the safety profile as generally acceptable when the drug is used as directed. The most common adverse effect noted is central nervous system depression, which can lead to drowsiness.


Q: Is it normal to feel no different when first starting Distamin?

Given that the onset of action is typically reported as occurring within 30 minutes to one hour, a prolonged absence of the desired effect may warrant professional consultation regarding the treatment plan.


Q: Can Distamin affect fertility in men or women?

Non-clinical studies in animals have examined the potential for effects on reproductive function and fertility. The relevance of these animal studies to human reproductive health is not clearly defined in clinical practice.


Q: Do patients typically need to take Distamin forever, or is treatment duration flexible?

The drug is indicated for the temporary relief of symptoms, which implies a flexible duration of use based on symptomatic need, rather than a fixed treatment period.


Q: What research themes are commonly explored in studies of Distamin?

Research cited in regulatory summaries focuses on key themes such as the medication's efficacy in allergic conditions. Other common themes explore its influence on the central nervous system (CNS) and its anticholinergic properties.


Q: Does Distamin cause drowsiness or fatigue that could impact daily activities?

Yes, drowsiness (somnolence) and fatigue are listed as common side effects in regulatory documents. Warnings are issued because the medicine has the potential to impair both mental and physical abilities.


Q: Are there any restrictions on driving or operating machinery while on Distamin?

Official warnings explicitly state that due to the risk of drowsiness and impaired coordination, caution should be exercised when driving or operating hazardous machinery until an individual is certain how the medication affects them.


Q: Do different forms of Distamin (e.g., tablet, liquid) have different instructions for use?

Yes, regulatory documents specify different administration constraints for various formulations. These include using an accurate measuring device for liquid forms and observing specific procedural constraints for injectable forms.


Q: What is the official classification of Distamin (e.g., controlled substance, prescription only)?

The official regulatory classification varies by country and formulation. The status of Distamin may range from over-the-counter (OTC) to prescription-only (Rx), depending on the specific rules of the local government authority.

How should Distamin be stored and disposed of?

Distamin (Penicillamine or Capecitabine, depending on the formulation) requires careful storage to maintain its effectiveness. Specific storage conditions vary, but generally, the medicine should be kept in its original, tightly closed container and stored at room temperature, typically below 25 C or 30 C, away from excessive moisture, heat, and direct sunlight. It is crucial to keep this medication out of the reach of children and pets.

Handling & Storage Recommendation
Temperature Do not store above 25 C or 30 C (check package)
Protection Keep the bottle tightly closed; protect from light and moisture
Access Keep out of the sight and reach of children and pets

Disposing of Distamin, especially if it is the chemotherapy agent Capecitabine, requires following specific instructions from your healthcare provider or pharmacist, as special handling may be necessary. For all formulations, never dispose of unused or expired medicine by flushing it down a toilet or pouring it into a drain, as this can harm the environment. The recommended method is often to use a community drug take-back program or follow local guidelines for household hazardous waste disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Distamin found in:

A-Z Index: